Hide filtersShow filters × Close Bryan, Garnier & Co acts as Sole Financial Advisor to Five Arrows on their equity investment in CBA Informatique Bryan, Garnier & Co acts as Co-manager for Ablynx Nasdaq IPO raising USD 230 million Bryan Garnier & Co acts as Sole Global Coordinator for Biom’Up’s landmark Euronext IPO, raising up to €44 million including greenshoe Bryan, Garnier & Co advises Initiative & Finance and ACG Management on the sale of Mediane to Turenne Bryan, Garnier & Co advises Abenex and the management team of Hygeco on their LBO Bryan, Garnier & Co acts as Joint Bookrunner of a private placement with US and European Investors raising €18 Million for Oryzon Upon pricing its landmark IPO on Euronext Paris led by Sole Global Coordinator Bryan, Garnier & Co, Symetis is acquired by Boston Scientific for USD 435 million PCI Biotech ASA Equity Issue Bryan, Garnier & Co advised Groupe Novasep on its divestiture of TangenX New challenger in spinal implants : Bryan, Garnier & Co advises Spineart on €30M Equity Investment from Gimv Bryan, Garnier & Co announces the successful USD 22 million / DKK 143 million follow-on offering for Zealand Pharma Bryan, Garnier & Co advised Briggs Healthcare in acquisition of SimpleLTC
